BioNTech (BNTX)
(Delayed Data from NSDQ)
$103.91 USD
-0.76 (-0.73%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $105.98 +2.07 (1.99%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
BioNTech SE Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BNTX 103.91 -0.76(-0.73%)
Will BNTX be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for BNTX
BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know
Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year?
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BNTX
BioNTech (BNTX) Revises 2025 Capital Expenditure Projections
BioNTech (BNTX) Reports Strong Q3 Revenue and Advances Oncology Strategy
BioNTech reports Q3 EPS EUR (0.12) vs. EUR 0.81 last year
BioNTech Reports Q3 2025 Financial Results with Revenue Growth Amid Operating Loss
BioNTech Reports Q3 2025 Financials and Raises Revenue Guidance